The Rise of Biosimilars and Generics
The Rise of Biosimilars and Generics: Navigating Challenges in a Shifting Pharmaceutical Landscape February 6, 2026 David Jolley 12:19 pm In the pharmaceutical industry, 2026 marks a pivotal moment where economic pressures, patent expirations, and policy shifts are propelling the generics and biosimilars market into unprecedented growth. As biotech firms grapple with stringent financing environments
The Rise of Biosimilars and Generics Read More »